Global, regional, and national burden and trends in chronic kidney disease attributable to metabolic risk, 1990-2021: based on global burden of disease data, 2021.
Abstract
Background
Global chronic kidney disease (CKD) burden from metabolic risks has risen steadily. Using 2021 Global Burden of Disease (GBD) data, this study examines 1990-2021 spatiotemporal trends and regional disparities in CKD to inform prevention.
Methods
We analyzed 1990-2021 GBD data on metabolic-related CKD burden globally. Outcomes included deaths and disability-adjusted life years (DALYs). The estimated annual percentage change (EAPC) and joinpoint analysis were used to assess temporal trends. Additionally, the methodology includes SDI correlation analysis, decomposition analysis, and BAPC modeling .
Results
Globally, deaths attributable to metabolic chronic kidney disease increased by 176%, while the annual rate of increase (ASMR) rose by 0.82%. Although the overall burden remains higher among males, young females aged 10 to 19 exhibit disproportionately high risk. Geographically, Ukraine, North America, and Venezuela experienced the most significant increases. Notably, despite the commonly observed inverse relationship between socioeconomic status index (SDI) and metabolic chronic kidney disease outcomes, the burden has rebounded in high-SDI regions. Population aging remains the primary driver of rising mortality. Projections indicate the global burden will peak around 2029, after which mortality is expected to stabilize and DALYs will moderately decline.
Conclusions
Metabolic risk is a primary driver of the complex global burden of CKD, with a resurgence observed in regions with high SDI. The multifactorial vulnerability faced by young women warrants particular attention. Future disease burden trends remain severe, necessitating urgent action to seize critical windows of opportunity through comprehensive lifestyle interventions and metabolic risk management.